Search results
Nearly 9 in 10 people say it’s a bad time to buy a house. ‘Consumers struggle to find the...
Market Watch· 19 minutes agoThe HPSI uses information from Fannie Mae’s National Housing Survey, which goes back to 2010. In May, 86% of consumers said it was a bad time to buy a house, up from 79% the ...
Madrigal shares maintain Buy rating on Phase 3 MAESTRO-NASH trial By Investing.com
Investing.com· 20 hours agoOn Thursday, Citi reiterated a Buy rating on Madrigal Pharmaceuticals (NASDAQ:MDGL), with a stock...
The Minimum Salary You Need To Be Happy in Every State
GOBankingRates via Yahoo Finance· 35 minutes agoCan money buy happiness? According to a Purdue University study published in the journal Nature...
3M (NYSE:MMM) Upgraded by Bank of America to “Buy”
ETF DAILY NEWS· 5 hours ago3M (NYSE:MMM – Get Free Report) was upgraded by investment analysts at Bank of America from a “neutral” rating to a “buy” rating in a research note issued on Friday, Marketbeat ...
Small Improvements in Mortgage Rates: Today's Mortgage Rates for June 7, 2024
CNET· 3 hours agoA couple of important mortgage rates are seeing dips. Lower mortgage rates could bring positive news...
Wall Street is putting its foot down as ‘Roaring Kitty’ strikes again
CNN Business via AOL· 2 hours agoKeith Gill, the “Roaring Kitty” meme stock investor, revealed in a Reddit post on Sunday that he had...
AutoZone shares hold Buy rating on strategic direction By Investing.com
Investing.com· 20 hours agoOn Thursday, TD (TSX:TD) Cowen maintained a positive outlook on AutoZone (NYSE:AZO) shares,...
Lam Research (NASDAQ:LRCX) Raised to “Buy” at StockNews.com
ETF DAILY NEWS· 10 hours agoLam Research (NASDAQ:LRCX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued ...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 6 hours agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 hour agoPfizer has also said it can jump in with a new pandemic influenza vaccine. Moderna stock has risen...
